Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer
CANCERS（2023）
Key words
biomarkers of systemic inflammation,Scottish Inflammatory Prognostic Score (SIPS),non-small-cell lung cancer,immune-related adverse events,pembrolizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined